Utility of the Beck Depression Inventory to screen for and track depression in injection drug users seeking hepatitis C treatment.

Publication Type:

Journal Article

Source:

General hospital psychiatry, Volume 32, Issue 4, p.426-32 (2010)

Keywords:

2010, Adult, Center-Authored Paper, Depressive Disorder, Female, Hepatitis C, Humans, Interferon Alfa-2a, Male, Polyethylene Glycols, Psychiatric Status Rating Scales, Reproducibility of Results, Sensitivity and Specificity, Substance Abuse, Intravenous, Vaccine and Infectious Disease Division

Abstract:

Treating acute hepatitis C (HCV) in injection drug users (IDUs) is complicated by a high prevalence of psychiatric comorbidities that may lead to increased risk for depressive complications of interferon treatment. Effective screening strategies are needed to help non-psychiatric clinicians identify depressive disorders.